{"schema_version":"alpha-profile-public-v1","slug":"martin-babler","canonical_url":"https://registry.alpha.ac/people/martin-babler","as_of":"2026-09-21T17:51:34.232651+00:00","published_at":"2026-09-02T02:37:22.461608+00:00","last_reviewed_at":"2026-05-16T01:59:08.744+00:00","identity":{"display_name":"Martin Babler","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Prelude Therapeutics Inc","company_slug":"prelude-therapeutics-inc","exchange":"NASDAQ","ticker":"PRLD","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm","effective_date":"2025-04-29","last_checked_at":"2026-04-28T23:35:02.22+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=martin-babler","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=martin-babler&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Martin Babler has served as President and CEO of Alumis Inc. since September 2021. Previously, he was President and CEO of Principia Biopharma until its acquisition by Sanofi in October 2020. He has extensive experience in the biopharmaceutical industry, including roles at Genentech and Eli Lilly."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Prelude Therapeutics Inc","organizationId":"prelude-therapeutics-inc","title":"Director","period":"2021-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Prelude Therapeutics Inc","company_slug":"prelude-therapeutics-inc","exchange":"NASDAQ","ticker":"PRLD","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm","effective_date":"2025-04-29","last_checked_at":"2026-04-28T23:35:02.22+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Martin Babler as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:59:08.916119+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PRLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-16T01:59:08.808436+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Martin Babler currently serves as Director at Prelude Therapeutics Inc.","claim_state":"verified","valid_from":"2025-04-29","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:59:08.880132+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PRLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-16T01:59:08.808436+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit"],"claim_text":"Martin Babler serves on Audit.","claim_state":"verified","valid_from":"2025-04-29","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:59:08.899575+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PRLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-16T01:59:08.808436+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Alumis Inc.","claim_text":"Martin Babler is linked to Alumis Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:59:09.008982+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PRLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-16T01:59:08.808436+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"President and Chief Executive Officer","claim_text":"Martin Babler is also listed as President and Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:59:08.993392+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PRLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-16T01:59:08.808436+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Martin Babler as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:59:08.948607+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PRLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-16T01:59:08.808436+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Martin Babler as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:59:08.933083+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PRLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-16T01:59:08.808436+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:martin-babler","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2021-01-01 · current","organization":"Prelude Therapeutics Inc","organization_id":"prelude-therapeutics-inc"},"claim_text":"Director at Prelude Therapeutics Inc (2021-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/martin-babler#profile","url":"https://registry.alpha.ac/people/martin-babler","dateModified":"2026-05-16T01:59:08.744+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/martin-babler#person","name":"Martin Babler","url":"https://registry.alpha.ac/people/martin-babler","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Prelude Therapeutics Inc","tickerSymbol":"NASDAQ: PRLD"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","memberOf":{"@type":"Organization","name":"Prelude Therapeutics Inc","url":"https://registry.alpha.ac/companies/prelude-therapeutics-inc","tickerSymbol":"NASDAQ: PRLD"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm","name":"PRLD DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/martin-babler"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T01:59:08.744+00:00","observed_at":"2026-09-21T17:51:34.232651+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"martin-babler","canonical_url":"https://registry.alpha.ac/people/martin-babler"},"publication":{"published_at":"2026-09-02T02:37:22.461608+00:00","last_reviewed_at":"2026-05-16T01:59:08.744+00:00","as_of":"2026-09-21T17:51:34.232651+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/martin-babler","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/martin-babler","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/martin-babler.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}